These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23845032)

  • 1. Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy.
    Guzhova IV; Shevtsov MA; Abkin SV; Pankratova KM; Margulis BA
    Int J Hyperthermia; 2013 Aug; 29(5):399-408. PubMed ID: 23845032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.
    Graner MW; Romanoski A; Katsanis E
    Int J Hyperthermia; 2013 Aug; 29(5):380-9. PubMed ID: 23725202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
    Calderwood SK; Theriault JR; Gong J
    Eur J Immunol; 2005 Sep; 35(9):2518-27. PubMed ID: 16144035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
    Nishikawa M; Takemoto S; Takakura Y
    Int J Pharm; 2008 Apr; 354(1-2):23-7. PubMed ID: 17980980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of heat shock proteins as regulators of apoptosis and innate immunity.
    Joly AL; Wettstein G; Mignot G; Ghiringhelli F; Garrido C
    J Innate Immun; 2010; 2(3):238-47. PubMed ID: 20375559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
    Li Y; Subjeck J; Yang G; Repasky E; Wang XY
    Vaccine; 2006 Jun; 24(25):5360-70. PubMed ID: 16714072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hsp70 chaperone and the prospects of its application in anticancer therapy].
    Guzhova IV; Novoselov SS; Margulis BA
    Tsitologiia; 2005; 47(3):187-99. PubMed ID: 16706162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dual role of chaperones in the response of a cell and of a whole organism to stress].
    Margulis BA; Guzhova IV
    Tsitologiia; 2009; 51(3):219-28. PubMed ID: 19435276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 70: role in antigen presentation and immune stimulation.
    Milani V; Noessner E; Ghose S; Kuppner M; Ahrens B; Scharner A; Gastpar R; Issels RD
    Int J Hyperthermia; 2002; 18(6):563-75. PubMed ID: 12537755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp70, a messenger from hyperthermia for the immune system.
    Jolesch A; Elmer K; Bendz H; Issels RD; Noessner E
    Eur J Cell Biol; 2012 Jan; 91(1):48-52. PubMed ID: 21458102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory functions of membrane-bound and exported heat shock protein 70.
    Radons J; Multhoff G
    Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How is the immune response affected by hyperthermia and heat shock proteins?
    Calderwood SK; Theriault JR; Gong J
    Int J Hyperthermia; 2005 Dec; 21(8):713-6. PubMed ID: 16338853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp70 chaperone as a survival factor in cell pathology.
    Guzhova I; Margulis B
    Int Rev Cytol; 2006; 254():101-49. PubMed ID: 17147998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.
    Ren W; Strube R; Zhang X; Chen SY; Huang XF
    Cancer Res; 2004 Sep; 64(18):6645-51. PubMed ID: 15374979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
    Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
    Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically modified tumour vaccines--where we are today.
    Nawrocki S; Mackiewicz A
    Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations.
    Calderwood SK; Gong J; Stevenson MA; Murshid A
    Int J Hyperthermia; 2013 Aug; 29(5):376-9. PubMed ID: 23682824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy.
    Schmitt E; Gehrmann M; Brunet M; Multhoff G; Garrido C
    J Leukoc Biol; 2007 Jan; 81(1):15-27. PubMed ID: 16931602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
    Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
    Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of human dendrite cells' physiological functions with the recombinant heat shock protein Hsp70].
    Pal'tsev MA; Severin SE; Danilevskiĭ MI; Moskaleva EIu
    Ross Fiziol Zh Im I M Sechenova; 2009 Oct; 95(10):1011-23. PubMed ID: 19957893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.